Funding
← Back to your selection

GV (Google Ventures)

Activity from announced rounds

Activity in this selectionSeries A

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
9
Confirmed lead rounds
0
8 roles undisclosed
New companies
9
First participation on record · 0 follow-on
Funding in participating rounds
$1.4B
9 disclosed · full round size, not this investor’s share

By stage

Series A9

By primary sector

AI2
Biotech2
Cybersecurity2
Climate tech1
Enterprise software1
1 more
Healthtech1

By country

United States6
United Kingdom2
France1

Rounds

9 in this selection
Estuary Biotherapeutics

Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.

$93MSeries A
Participant
MokN

Protects organisations from credential theft and identity-based attacks through active identity recovery technology

$15MSeries A
Role not disclosed
Nectar Social

Provides AI infrastructure for modern marketing

$30MSeries A
Role not disclosed
Recursive Superintelligence

Develops self-improving AI systems that autonomously enhance their own architecture and training algorithms

$650MSeries A
Role not disclosed
Translucent

Provides AI platform for healthcare finance

$27MSeries A
Role not disclosed
SolveAI

Enables employees to build enterprise-grade apps using natural language with secure IT integration

$45MSeries A
Role not disclosed
Complyance

Uses AI agents to manage governance risk and data compliance for enterprises

$20MSeries A
Role not disclosed
Prudentia Sciences

Provides AI-native due diligence for life sciences dealmaking

$20MSeries A
Role not disclosed